Literature DB >> 7463700

Evaluating the superior vena cava syndrome.

D S Shimm, G L Logue, L C Rigsby.   

Abstract

We reviewed the records of 28 patients with superior vena cava syndrome (SVCS) between 1973 and 1978 to establish the risk from invasive diagnostic procedures and the therapeutic value of the information obtained. Of 23 patients, this syndrome was the initial manifestation in 18. Bronchoscopy with endobronchial biopsy, thoracentesis, pleural biopsy, lymph node biopsy, and, in one patient, thoracotomy were performed without major complications. Small cell undifferentiated carcinoma of the lung was found in seven of the 18 patients with SVCS as the initial manifestation of their disease. We believe that carefully performed invasive diagnostic procedures can be carried out safely. Furthermore, accurate histological diagnosis assumes major importance with the development of effective chemotherapy for small cell undifferentiated carcinoma of the lung.

Entities:  

Mesh:

Year:  1981        PMID: 7463700

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  2 in total

1.  Malignant pleural mesothelioma presenting as superior vena cava syndrome.

Authors:  G F Ragalie; B Varkey; H Choi
Journal:  Can Med Assoc J       Date:  1983-03-15       Impact factor: 8.262

2.  Computed tomographic evaluation of compression of the superior vena cava and its tributaries.

Authors:  W F Tatu; G G Winzelberg; M Boller; M H Wholey
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.